v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss from continuing operations $ (43,507,142) $ (18,778,876)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 2,000 2,000
Amortization of intangible assets 453,846
Change in fair value of warrant liability (909,020) 182,982
Change in fair value of derivative liability (2,296,834) (180,383)
Loss on conversion of note payable 53,446
Loss on disposition of subsidiaries 214,486
Stock-based compensation 2,068,892 25,584
Common stock issued for services 4,310,090 4,598,294
Goodwill impairment 26,346,050
Impairment of investment 2,500,000
Amortization of debt discount 3,161,100 912,447
Amortization of right-of-use assets 35,935 51,361
Interest income (250,000)
Changes in operating assets and liabilities:    
Accounts receivable, net (720,222) (11,106)
Prepaid expenses and deposits (193,023) 34,656
Inventory (213,408) 968
Other receivables (80,469) (2,914,068)
Lease liability (36,979) (51,587)
Accounts payable (1,567,215) 448,572
Accrued liabilities (248,574) (44,616)
Current liabilities (5,441) (62,390)
Net cash used in operating activities from continuing operations (13,382,482) (13,286,163)
Net cash provided by (used in) operating activities from discontinued operations 2,799 (979,075)
Net cash used in operating activities (13,379,683) (14,265,239)
Cash flows from investing activities:    
Cash received in acquisition 132,976
Acquisition of property and equipment (12,000)
Investment in securities (2,500,000)
Net cash used in investing activities from continuing operations (2,379,024)
Net cash provided by investing activities from discontinued operations 29,931,815
Net cash provided by investing activities 27,552,791
Cash flows from financing activities:    
Repayment of contingent liability (1,246,346)
Proceeds from loan payable, related party 116,000 150,000
Repayment of loan payable, related party (531,000)
Proceeds from issuance of convertible notes, net of issuance costs 2,954,000
Proceeds from convertible notes 3,500,000
Repayment of convertible notes (9,244,444)
Gross proceeds from issuance of common stock 26,293,039
Repayment of development liability (400,000)
Cash dividends paid (14,858,831)
Proceeds from exercise of warrants 16,567
Proceeds from exercise of options 9,840
Net cash provided by (used in) financing activities from continuing operations 19,733,595 (12,974,770)
Net cash used in financing activities from discontinued operations (5,000)
Net cash provided by (used in) financing activities 19,733,595 (12,979,770)
Net change in cash 6,353,912 307,782
Cash at beginning of period 308,096 314
Cash at end of period 6,662,008 308,096
Supplemental disclosure of cash flow information:    
Cash paid for interest
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of note payable into common stock 411,000
Equity line of commitment shares issued as offering costs 1,526,318 534,800
Issuance of note receivable in exchange for other receivables 5,000,000
Issuance of shares pursuant to Merger 78,646,184
Assets acquired in connection with Merger 194,554
Liabilities assumed in connection with Merger 5,797,117
Insurance premium financed 198,245
Issuance of common shares in connection with converible debenture 420,200
Deferred offering costs 69,444
Derivative liability recognized in connection with issuance of convertible note 2,477,217
Warrants issued with convertible note 71,332
Common stock issued for convertible note settlement 189,673
Common stock issued for convertible note extension 175,250
Accretion of original issue discount on Treasury Bills $ 20,625